Todd Sarge1, Elias Baedorf-Kassis2, Valerie Banner-Goodspeed1, Victor Novack3, Stephen H Loring1, Michelle N Gong4, Deborah Cook5, Daniel Talmor1, Jeremy R Beitler6. 1. Department of Anesthesia, Critical Care, and Pain Medicine and. 2. Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 3. Soroka Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel. 4. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York. 5. St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada; and. 6. Center for Acute Respiratory Failure, Division of Pulmonary, Allergy, and Critical Care Medicine, NewYork-Presbyterian Hospital, College of Physicians and Surgeons, Columbia University, New York, New York.
Abstract
Rationale: In acute respiratory distress syndrome (ARDS), the effect of positive end-expiratory pressure (PEEP) may depend on the extent to which multiorgan dysfunction contributes to risk of death, and the precision with which PEEP is titrated to attenuate atelectrauma without exacerbating overdistension. Objectives: To evaluate whether multiorgan dysfunction and lung mechanics modified treatment effect in the EPVent-2 (Esophageal Pressure-guided Ventilation 2) trial, a multicenter trial of esophageal pressure (Pes)-guided PEEP versus empirical high PEEP in moderate to severe ARDS. Methods: This post hoc reanalysis of the EPVent-2 trial evaluated for heterogeneity of treatment effect on mortality by baseline multiorgan dysfunction, determined via Acute Physiology and Chronic Health Evaluation II (APACHE-II). It also evaluated whether PEEP titrated to end-expiratory transpulmonary pressure near 0 cm H2O was associated with survival. Measurements and Main Results: All 200 trial participants were included. Treatment effect on 60-day mortality differed by multiorgan dysfunction severity (P = 0.03 for interaction). Pes-guided PEEP was associated with lower mortality among patients with APACHE-II less than the median value (hazard ratio, 0.43; 95% confidence interval, 0.20-0.92) and may have had the opposite effect in patients with higher APACHE-II (hazard ratio, 1.69; 95% confidence interval, 0.93-3.05). Independent of treatment group or multiorgan dysfunction severity, mortality was lowest when PEEP titration achieved end-expiratory transpulmonary pressure near 0 cm H2O. Conclusions: The effect on survival of Pes-guided PEEP, compared with empirical high PEEP, differed by multiorgan dysfunction severity. Independent of multiorgan dysfunction, PEEP titrated to end-expiratory transpulmonary pressure closer to 0 cm H2O was associated with greater survival than more positive or negative values. These findings warrant prospective testing in a future trial.
Rationale: In acute respiratory distress syndrome (ARDS), the effect of positive end-expiratory pressure (PEEP) may depend on the extent to which multiorgan dysfunction contributes to risk of death, and the precision with which PEEP is titrated to attenuate atelectrauma without exacerbating overdistension. Objectives: To evaluate whether multiorgan dysfunction and lung mechanics modified treatment effect in the EPVent-2 (Esophageal Pressure-guided Ventilation 2) trial, a multicenter trial of esophageal pressure (Pes)-guided PEEP versus empirical high PEEP in moderate to severe ARDS. Methods: This post hoc reanalysis of the EPVent-2 trial evaluated for heterogeneity of treatment effect on mortality by baseline multiorgan dysfunction, determined via Acute Physiology and Chronic Health Evaluation II (APACHE-II). It also evaluated whether PEEP titrated to end-expiratory transpulmonary pressure near 0 cm H2O was associated with survival. Measurements and Main Results: All 200 trial participants were included. Treatment effect on 60-day mortality differed by multiorgan dysfunction severity (P = 0.03 for interaction). Pes-guided PEEP was associated with lower mortality among patients with APACHE-II less than the median value (hazard ratio, 0.43; 95% confidence interval, 0.20-0.92) and may have had the opposite effect in patients with higher APACHE-II (hazard ratio, 1.69; 95% confidence interval, 0.93-3.05). Independent of treatment group or multiorgan dysfunction severity, mortality was lowest when PEEP titration achieved end-expiratory transpulmonary pressure near 0 cm H2O. Conclusions: The effect on survival of Pes-guided PEEP, compared with empirical high PEEP, differed by multiorgan dysfunction severity. Independent of multiorgan dysfunction, PEEP titrated to end-expiratory transpulmonary pressure closer to 0 cm H2O was associated with greater survival than more positive or negative values. These findings warrant prospective testing in a future trial.
Authors: Theodore J Iwashyna; James F Burke; Jeremy B Sussman; Hallie C Prescott; Rodney A Hayward; Derek C Angus Journal: Am J Respir Crit Care Med Date: 2015-11-01 Impact factor: 21.405
Authors: Jeremy R Beitler; Rohit Majumdar; Rolf D Hubmayr; Atul Malhotra; B Taylor Thompson; Robert L Owens; Stephen H Loring; Daniel Talmor Journal: Crit Care Med Date: 2016-01 Impact factor: 7.598
Authors: Stephen H Loring; Carl R O'Donnell; Negin Behazin; Atul Malhotra; Todd Sarge; Ray Ritz; Victor Novack; Daniel Talmor Journal: J Appl Physiol (1985) Date: 2009-12-17
Authors: Jesse Liou; Daniel Doherty; Tom Gillin; John Emberger; Yeonjoo Yi; Luis Cardenas; Michael Benninghoff; Michael Vest; Andrew Deitchman Journal: Crit Care Explor Date: 2022-04-29
Authors: Jesús Villar; Carlos Ferrando; Gerardo Tusman; Lorenzo Berra; Pedro Rodríguez-Suárez; Fernando Suárez-Sipmann Journal: Front Physiol Date: 2021-11-30 Impact factor: 4.566
Authors: Christoph Boesing; Peter T Graf; Fabian Schmitt; Manfred Thiel; Paolo Pelosi; Patricia R M Rocco; Thomas Luecke; Joerg Krebs Journal: Crit Care Date: 2022-03-26 Impact factor: 9.097
Authors: Adnan Liaqat; Matthew Mason; Brian J Foster; Sagar Kulkarni; Aisha Barlas; Awais M Farooq; Pooja Patak; Hamza Liaqat; Rafaela G Basso; Mohammed S Zaman; Dhaval Pau Journal: J Clin Med Date: 2022-01-10 Impact factor: 4.241